Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ngm Biopharmaceuticals Inc (NGM)  
$1.54 0.00 (0.00%) as of 4:30 Thu 4/4


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 69,020,000
Market Cap: 106.29(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6003 - $4.53
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   NGM Biopharmaceuticals is a biopharmaceutical company. Co. has five product candidates in the clinic, three wholly-owned by Co. (NGM707, NGM120 and aldafermin), one being progressed by its collaborator, Merck Sharp & Dohme Corp., or Merck (MK-3655) and one optionable by Merck (NGM621). Co.'s oncology product candidates include NGM707, NGM831, NGM438 and NGM120 and their related compounds. NGM621 was engineered to bind to, and be a long-acting inhibitor of, complement C3 with the treatment goal of reducing disease progression in patients with geographic atrophy, secondary to age-related macular degeneration. MK-3655 isin Phase 2b development for the treatment of nonalcoholic steatohepatitis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 94,704 94,704 9,606,382
Total Buy Value $0 $64,854 $64,854 $87,820,003
Total People Bought 0 4 4 5
Total Buy Transactions 0 10 10 130
Total Shares Sold 0 0 0 85,082
Total Sell Value $0 $0 $0 $438,308
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-01-18 2023-10-17 2023-04-18 2022-04-18

   
Records found: 154
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Pierce Valerie L SVP, GC & CCO   •       –      –    2023-03-02 4 A $0.00 $0 D/D 49,000 55,667     -
   Chen Jin-Long Chief Scientific Officer   •       •      –    2023-03-02 4 A $0.00 $0 D/D 64,000 972,893     -
   Nolan Mangini Siobhan President and CFO   •       –      –    2023-03-02 4 A $0.00 $0 D/D 76,000 76,000     -
   Lieu Hsiao SVP, Chief Medical Officer   •       –      –    2023-03-02 4 A $0.00 $0 D/D 53,000 55,605     -
   Woodhouse David J Chief Executive Officer   •       •      –    2023-03-02 4 A $0.00 $0 D/D 127,200 144,854     -
   Tcg Opportunity Iii Gp, Llc 10% Owner   –       –       •   2023-01-31 4 B $5.00 $883,403 I/I 176,730 927,231 1.5 -35%     
   Goeddel David V Director   –       •       •   2023-01-31 4 B $5.00 $883,403 I/I 176,730 927,231 2.25 -35%     
   Column Group Opportunity Iii Gp, Lp 10% Owner   –       –       •   2023-01-31 4 B $5.00 $883,403 I/I 176,730 927,231 1.5 -35%     
   Column Group Ii Gp, Lp 10% Owner   –       –       •   2023-01-31 4 B $5.00 $883,403 I/I 176,730 927,231 1.5 -35%     
   Tcg Opportunity Iii Gp, Llc 10% Owner   –       –       •   2023-01-30 4 B $5.00 $37,707 I/I 7,542 750,501 1.5 -31%     
   Goeddel David V Director   –       •       •   2023-01-30 4 B $5.00 $37,707 I/I 7,542 750,501 2.25 -31%     
   Column Group Opportunity Iii Gp, Lp 10% Owner   –       –       •   2023-01-30 4 B $5.00 $37,707 I/I 7,542 750,501 1.5 -31%     
   Column Group Ii Gp, Lp 10% Owner   –       –       •   2023-01-30 4 B $5.00 $37,707 I/I 7,542 750,501 1.5 -31%     
   Column Group Opportunity Iii Gp, Lp 10% Owner   –       –       •   2023-01-23 4 B $5.00 $49,494 I/I 9,900 742,959 1.5 -38%     
   Column Group Ii Gp, Lp General Partner   –       –       •   2023-01-23 4 B $5.00 $49,494 I/I 9,900 742,959 1.5 -38%     
   Goeddel David V Director   –       •       •   2023-01-23 4 B $5.00 $49,494 I/I 9,900 742,959 2.25 -38%     
   Tcg Opportunity Iii Gp, Llc 10% Owner   –       –       •   2023-01-23 4 B $5.00 $49,494 I/I 9,900 742,959 1.5 -38%     
   Goeddel David V Director   –       •       •   2023-01-20 4 B $5.00 $2,498 I/I 500 733,059 2.17 -40%     
   Tcg Opportunity Iii Gp, Llc 10% Owner   –       –       •   2023-01-20 4 B $5.00 $2,498 I/I 500 733,059 1.42 -40%     
   Column Group Ii Gp, Lp 10% Owner   –       –       •   2023-01-20 4 B $5.00 $2,498 I/I 500 733,059 1.42 -40%     
   Column Group Opportunity Iii Gp, Lp 10% Owner   –       –       •   2023-01-20 4 B $5.00 $2,498 I/I 500 733,059 1.42 -40%     
   Goeddel David V Director   –       •       •   2023-01-19 4 B $5.00 $188,105 I/I 37,639 732,559 2.25 -41%     
   Tcg Opportunity Iii Gp, Llc 10% Owner   –       –       •   2023-01-19 4 B $5.00 $188,105 I/I 37,639 732,559 1.5 -41%     
   Column Group Ii Gp, Lp 10% Owner   –       –       •   2023-01-19 4 B $5.00 $188,105 I/I 37,639 732,559 1.5 -41%     
   Column Group Opportunity Iii Gp, Lp 10% Owner   –       –       •   2023-01-19 4 B $5.00 $188,105 I/I 37,639 732,559 1.5 -41%     
  154 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us